TGF-β overexpression has been demonstrated in both animal and human tumor models and is seen clinically in many tumors including cancers of the breast, colon, esophagus, stomach, liver, lung, kidney, pancreas, prostate, brain, and malignant melanoma, as well as certain hematological malignancies [38]. Here, TGFB1 is linked to breast cancer.